Medicure Inc MCUJF:OTCPK

RT Quote | Exchange | USD
Last | 10:57 AM EST
1.16quote price arrow up+0.02 (+1.84%)
Volume
783
52 week range
0.56 - 1.94

...

Loading . . .

KEY STATS

  • Open1.16
  • Day High1.16
  • Day Low1.16
  • Prev Close1.14
  • 52 Week High1.94
  • 52 Week High Date04/15/20
  • 52 Week Low0.56
  • 52 Week Low Date11/25/20
  • Market Cap11.90M
  • Shares Out10.25M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • 1 Year % Change-36.24

RATIOS/PROFITABILITY

  • EPS (TTM)-0.99
  • P/E (TTM)-1.18
  • Fwd P/E (NTM)-5.16
  • EBITDA (MRQ)-4.056M
  • ROE (MRQ)-36.60%
  • Revenue (MRQ)10.04M
  • Gross Margin (MRQ)38.89%
  • Net Margin (MRQ)-141.38%
  • Debt To Equity (MRQ)6.83%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Medicure Inc News

There is no recent news for this security.

Latest MCUJF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Medicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company operates in the biopharmaceutical industry segment. The Company's primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the...
Albert Friesen Ph.D.
Chairman
Neil Owens
President
James Kinley CA
Chief Financial Officer
Address
1250 Waverley St Suite 2
Winnipeg, MB
R3T 6C6
Canada